Platelets' RNA as biomarker trove for differentiation of early-stage hepatocellular carcinoma from underlying cirrhotic nodules.
<h4>Background & aims</h4>Among the multiplicity of factors involved in rising incidence of hepatocellular carcinoma (HCC)-the second deadliest cancer, late diagnosis of early-stage HCC nodules originating from late-stage cirrhotic nodules is the most crucial. In recent years, Tumor-...
Guardado en:
Autores principales: | Walifa Waqar, Sidra Asghar, Sobia Manzoor |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7a92a7447fe74c5dbce503d3d2daf94c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Transthyretin as a Novel Biomarker for Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients
por: Magda Ibrahim, et al.
Publicado: (2020) -
Eag1 channels as potential early-stage biomarkers of hepatocellular carcinoma
por: Chávez-López MG, et al.
Publicado: (2016) -
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals
por: Benedetta Donati, et al.
Publicado: (2017) -
MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma.
por: Chan Xie, et al.
Publicado: (2013) -
Low serum magnesium concentration is associated with the presence of viable hepatocellular carcinoma tissue in cirrhotic patients
por: Simona Parisse, et al.
Publicado: (2021)